Related Experiment Video
Updated: May 16, 2026
Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
Published on: September 30, 2021
New challenges in hemophilia: long-term outcomes and complications
1Hemostasis and Thrombosis Center, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA 90027, USA. gyoung@chla.usc.edu
Insights
Hemophilia care has advanced, but new challenges emerge. These include adopting novel treatments, managing comorbidities like obesity and osteoporosis, rising costs, and addressing the lack of care in developing nations.
Area of Science:
- Hematology
- Public Health
Background:
- Hemophilia patient care has seen significant advancements over the last 50 years, enabling normal lifespans in developed countries.
- Improved treatments have led to better quality of life but introduced new health concerns for hemophilia patients.
Purpose of the Study:
- To review emerging challenges in hemophilia care.
- To highlight issues facing developing nations in managing hemophilia.
Main Methods:
- This is a review article discussing current and future challenges in hemophilia care.
- The review synthesizes information on treatment advancements, patient comorbidities, healthcare costs, and global disparities in care.
Main Results:
- New treatments require integration into clinical practice.
- Obesity, osteoporosis, and hemophilic arthropathy are increasing morbidities.
- Rising treatment costs and significant care gaps in developing nations pose major challenges.
Conclusions:
- Hemophilia care faces a complex future with evolving treatment landscapes and persistent global inequities.
- Addressing these multifaceted challenges is crucial for improving patient outcomes worldwide.
Abstract:
For the past 5 decades, the care for hemophilia patients has improved significantly to the point that a newborn with hemophilia living in a developed nation can expect to have a normal lifespan and a high quality of life. Despite this, there are several new challenges that the hemophilia community will face in the coming years. First, the hemophilia community will soon be challenged with adopting a variety of new agents into clinical practice. Second, the normalization of patients' lives as a result of improved treatment has led to new problem areas, including obese/overweight hemophiliacs and osteoporosis. In addition, although mortality rates are similar to those of the healthy population, morbidities such as hemophilic arthropathy still occur. Third, the cost of care continues to rise, both due to the development of expensive new therapies and to the costs of managing problems such as obesity and osteoporosis. Finally, most patients in the world with hemophilia receive little to no care and although this is an enormous challenge, it must be confronted. This review discusses some new challenges facing developing nations and their care for hemophilia patients. In summary, in hemophilia in the coming few years, several new challenges will need to be confronted.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
01:24Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
01:24Healing II: Complications
01:30Venous Thrombosis IV: Nursing Management
01:20Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...